English
Insider transactions
EDGARBlossomHill Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 7 transactions, 1,573,900 shares
- Sum of shares × price per share: 25,181,900
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–43 of 43
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 Filed 2026-08-12 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Acquired (A) | 1,039,996 | — | — | 1,039,996 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000784 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Acquired (A) | 1,049,283 | — | — | 2,089,279 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000784 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 625,000 | 16.00 | 10,000,000Derived: shares × price per share. Exact value 10000000.00. | 2,714,279 | Indirect (I) See footnotes | No | F2, F3, F4
| Open filing 0000947871-26-000784 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Disposed (D) | 1,039,996 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000784 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Disposed (D) | 1,049,283 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000784 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | GORDON CARL L Director | CConversion of derivative security | Acquired (A) | 1,039,996 | — | — | 1,039,996 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000785 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | GORDON CARL L Director | CConversion of derivative security | Acquired (A) | 1,049,283 | — | — | 2,089,279 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000785 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | GORDON CARL L Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 625,000 | 16.00 | 10,000,000Derived: shares × price per share. Exact value 10000000.00. | 2,714,279 | Indirect (I) See footnotes | No | F2, F3, F4
| Open filing 0000947871-26-000785 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | GORDON CARL L Director | CConversion of derivative security | Disposed (D) | 1,039,996 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000785 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-12 | GORDON CARL L Director | CConversion of derivative security | Disposed (D) | 1,049,283 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000785 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | CConversion of derivative security | Acquired (A) | 1,599,993 | — | — | 1,599,993 | Indirect (I) See footnotes | No | F1, F2, F3, F4
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | CConversion of derivative security | Acquired (A) | 1,701,541 | — | — | 3,301,534 | Indirect (I) See footnotes | No | F5, F2, F6, F3, F4
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 312,500 | 16 | 5,000,000Derived: shares × price per share. Exact value 5000000. | 3,614,034 | Indirect (I) See footnotes | No | F7, F8, F3, F4
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | CConversion of derivative security | Disposed (D) | 1,599,993 | — | — | 0 | Indirect (I) See footnotes | No | F2, F1, F3, F4
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | CConversion of derivative security | Disposed (D) | 1,701,541 | — | — | 0 | Indirect (I) See footnotes | No | F2, F5, F3, F4
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Liptak Vincent Paul Officer: General Counsel | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,200 | 16 | 35,200Derived: shares × price per share. Exact value 35200. | 111,412 | Direct (D) | No | — | Open filing 0002143905-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Liptak Vincent Paul Officer: General Counsel | CConversion of derivative security | Acquired (A) | 22,687 | — | — | 22,687 | Indirect (I) By Walter T. Liptak Revocable Trust | No | F1, F2
| Open filing 0002143905-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Liptak Vincent Paul Officer: General Counsel | CConversion of derivative security | Disposed (D) | 22,687 | — | — | 0 | Indirect (I) By Walter T. Liptak Revocable Trust | No | F1, F2
| Open filing 0002143905-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Schmid John P. Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,000 | 16 | 96,000Derived: shares × price per share. Exact value 96000. | 6,000 | Direct (D) | No | — | Open filing 0001478916-26-000015 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Agrawal Sundeep Director | CConversion of derivative security | Acquired (A) | 578,524 | — | — | 578,524 | Indirect (I) By Brahma BlossomHill Partners, LLC | No | F1, F2
| Open filing 0001840599-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Agrawal Sundeep Director | CConversion of derivative security | Disposed (D) | 578,524 | — | — | 0 | Indirect (I) By Brahma BlossomHill Partners, LLC | No | F1, F2
| Open filing 0001840599-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Acquired (A) | 1,600,682 | — | — | 1,600,682 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Acquired (A) | 113,435 | — | — | 1,714,117 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Acquired (A) | 124,779 | — | — | 124,779 | Indirect (I) By RongShan, LLC | No | F1, F3
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Disposed (D) | 1,600,682 | — | — | 0 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Disposed (D) | 113,435 | — | — | 0 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | CConversion of derivative security | Disposed (D) | 124,779 | — | — | 0 | Indirect (I) By RongShan, LLC | No | F1, F3
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Keyes Jason A Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 700 | 16 | 11,200Derived: shares × price per share. Exact value 11200. | 700 | Direct (D) | No | — | Open filing 0001678152-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Acquired (A) | 1,600,682 | — | — | 1,600,682 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Acquired (A) | 113,435 | — | — | 1,714,117 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Acquired (A) | 124,779 | — | — | 124,779 | Indirect (I) By RongShan, LLC | No | F1, F3
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Disposed (D) | 1,600,682 | — | — | 0 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Disposed (D) | 113,435 | — | — | 0 | Indirect (I) By The Li and Cui Family Trust | No | F1, F2
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | CConversion of derivative security | Disposed (D) | 124,779 | — | — | 0 | Indirect (I) By RongShan, LLC | No | F1, F3
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-10 | Liptak Vincent Paul Officer: General Counsel | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,500 | 15.80 | 39,500Derived: shares × price per share. Exact value 39500.00. | 109,212 | Direct (D) | No | — | Open filing 0002143905-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Chen Bihua Director · 10% ownerCormorant Asset Management, LP 10% ownerCormorant Global Healthcare Master Fund, LP 10% ownerCormorant Private Healthcare Fund III LP 10% ownerCormorant Private Healthcare Fund V LP 10% ownerCormorant Private Healthcare Fund VI, LP 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,904 | 0 | — | 23,904 | Direct (D) | No | F9
| Open filing 0001231919-26-000852 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | GORDON CARL L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,904 | 0 | — | 23,904 | Direct (D) | No | F1, F2
| Open filing 0001282930-26-000008 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Liptak Vincent Paul Officer: General Counsel | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 46,561 | 0 | — | 46,561 | Direct (D) | No | F3
| Open filing 0002143905-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Agrawal Sundeep Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,904 | 0 | — | 23,904 | Direct (D) | No | F3
| Open filing 0001840599-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Oxnard Geoffrey Raymond Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 61,783 | 0 | — | 61,783 | Direct (D) | No | F1
| Open filing 0002144320-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Cui Jingrong Jean Director · Officer: President and CEO · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 676,205 | 0 | — | 676,205 | Direct (D) | No | F4
| Open filing 0001772259-26-000005 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Keyes Jason A Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 56,746 | 0 | — | 56,746 | Direct (D) | No | F1
| Open filing 0001678152-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-06 Filed 2026-08-10 | Li Yishan Director · Officer: Executive Chairman · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 112,701 | 0 | — | 112,701 | Direct (D) | No | F4
| Open filing 0001772233-26-000005 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–39 of 39
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Cormorant Asset Management, LP Partly reported under another manager | 3,614,034 SH | 67,365,594 dollars | Not in the prior quarter’s filings read | Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row |
| ORBIMED ADVISORS LLC | 2,714,279 SH | 50,594,161 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 1,812,193 SH | 33,779,278 dollars | Not in the prior quarter’s filings read | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| Vivo Capital, LLC | 1,493,740 SH | 27,843,314 dollars | Not in the prior quarter’s filings read | Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row |
| DEERFIELD MANAGEMENT COMPANY, L.P. Partly reported under another manager | 1,446,000 SH | 26,953,440 dollars | Not in the prior quarter’s filings read | Open filing 0001213900-26-120609 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 1,415,331 SH | 30,245,624 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 1,336,993 SH | 24,861,385 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 1,027,293 SH | 19,148,742 dollars | Not in the prior quarter’s filings read | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 433,302 SH | 8,076,749 dollars | Not in the prior quarter’s filings read | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| NEXTBio Capital Management LP | 250,000 SH | 4,660,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-004969 Filed 2026-11-13 Dispute this row |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,104 SH | 3,767,219 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row |
| Opaleye Management Inc. | 175,000 SH | 3,262,000 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 147,686 SH | 2,752,867 dollars | Not in the prior quarter’s filings read | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| a16z Capital Management, L.L.C. | 125,000 SH | 2,330,000 dollars | Not in the prior quarter’s filings read | Open filing 0001540358-26-000014 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 119,176 SH | 2,222,828 dollars | Not in the prior quarter’s filings read | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Monashee Investment Management LLC | 80,000 SH | 1,491,200 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-004876 Filed 2026-11-06 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 73,691 SH | 1,373,600 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 60,281 SH | 1,123,638 dollars | Not in the prior quarter’s filings read | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| CITADEL ADVISORS LLC | 55,000 SH | 1,025,200 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Ghisallo Capital Management LLC | 50,000 SH | 932,000 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005189 Filed 2026-11-16 Dispute this row |
| Birchview Capital, LP | 50,000 SH | 932,000 dollars | Not in the prior quarter’s filings read | Open filing 0001618205-26-000005 Filed 2026-11-13 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 45,818 SH | 854,048 dollars | Not in the prior quarter’s filings read | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 30,805 SH | 574,205 dollars | Not in the prior quarter’s filings read | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Walleye Capital LLC | 28,659 SH | 534,204 dollars | Not in the prior quarter’s filings read | Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 23,150 SH | 431,516 dollars | Not in the prior quarter’s filings read | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 21,337 SH | 397,722 dollars | Not in the prior quarter’s filings read | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 17,200 SH | 320,608 dollars | Not in the prior quarter’s filings read | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 12,034 SH | 224,314 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10,932 SH | 203,772 dollars | Not in the prior quarter’s filings read | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| Jump Financial, LLC Partly reported under another manager | 10,223 SH | 190,557 dollars | Not in the prior quarter’s filings read | Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 10,194 SH | 190,016 dollars | Not in the prior quarter’s filings read | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 10,100 SH | 188,264 dollars | Not in the prior quarter’s filings read | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| Aster Capital Management (DIFC) Ltd Partly reported under another manager | 4,822 SH | 89,882 dollars | Not in the prior quarter’s filings read | Open filing 0002040915-26-000006 Filed 2026-11-12 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 4,677 SH | 87,180 dollars | Not in the prior quarter’s filings read | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Vanguard Global Advisers, LLC | 3,765 SH | 70,180 dollars | Not in the prior quarter’s filings read | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| Legal General Group Plc Partly reported under another manager | 1,612 SH | 30,836 dollars | Not in the prior quarter’s filings read | Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 1,279 SH | 23,841 dollars | Not in the prior quarter’s filings read | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| UBS Group AG Partly reported under another manager | 997 SH | 18,584 dollars | Not in the prior quarter’s filings read | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 512 SH | 10,941 dollars | Not in the prior quarter’s filings read | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Vivo Innovation Fund II Holdings, L.P. Common Stock, par value $0.0001 per share | 4.7 | 1,493,740.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-120149 Dispute this row |
| Vivo Innovation II, LLC Common Stock, par value $0.0001 per share | 4.7 | 1,493,740.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-120149 Dispute this row |
| Jingrong Jean Cui Common Stock, $0.0001 par value per share | 12.5 | 3,973,138 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001193125-26-464174 Dispute this row |
| Yishan Li Common Stock, $0.0001 par value per share | 12.5 | 3,973,138 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001193125-26-464174 Dispute this row |
| JANUS HENDERSON GROUP Ltd. Common Shares | 7.8 | 2,471,354 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001274173-26-000283 Dispute this row |
| ORBIMED ADVISORS LLC Common Stock | 8.9 | 2,714,279.00 | 08/10/2026 Filed 2026-08-18 | SCHEDULE 13D | Open filing 0000947871-26-000813 Dispute this row |
| OrbiMed Capital GP VIII LLC Common Stock | 8.9 | 2,714,279.00 | 08/10/2026 Filed 2026-08-18 | SCHEDULE 13D | Open filing 0000947871-26-000813 Dispute this row |
| Vivo Innovation Fund II Holdings, L.P. Common Stock, par value $0.0001 per share | 5.5 | 1,681,240.00 | 08/10/2026 Filed 2026-08-17 | SCHEDULE 13G | Open filing 0001213900-26-090726 Dispute this row |
| Vivo Innovation II, LLC Common Stock, par value $0.0001 per share | 5.5 | 1,681,240.00 | 08/10/2026 Filed 2026-08-17 | SCHEDULE 13G | Open filing 0001213900-26-090726 Dispute this row |
| Perceptive Advisors LLC Common Stock, par value $0.0001 | 5.9 | 1,808,533 | 08/07/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001193125-26-352634 Dispute this row |
| Joseph Edelman Common Stock, par value $0.0001 | 5.9 | 1,808,533 | 08/07/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001193125-26-352634 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 | 5.9 | 1,808,533 | 08/07/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001193125-26-352634 Dispute this row |
| Cormorant Global Healthcare Master Fund, LP Common Stock, $0.0001 par value per share | 3.13 | 959,090 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Global Healthcare GP, LLC Common Stock, $0.0001 par value per share | 3.13 | 959,090 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare Fund III, LP Common Stock, $0.0001 par value per share | 4.01 | 1,228,315 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare GP III, LLC Common Stock, $0.0001 par value per share | 4.01 | 1,228,315 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare Fund V, LP Common Stock, $0.0001 par value per share | 3.43 | 1,052,460 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare GP V, LLC Common Stock, $0.0001 par value per share | 3.43 | 1,052,460 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare Fund VI, LP Common Stock, $0.0001 par value per share | 1.22 | 374,169 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Private Healthcare GP VI, LLC Common Stock, $0.0001 par value per share | 1.22 | 374,169 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Cormorant Asset Management, LP Common Stock, $0.0001 par value per share | 11.79 | 3,614,034 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
| Chen Bihua Common Stock, $0.0001 par value per share | 11.8 | 3,615,362 | 08/06/2026 Filed 2026-08-13 | SCHEDULE 13D | Open filing 0000929638-26-003026 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,566,580 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 192,873 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.